Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth
Anthony M. Barsotti(Pfizer (United States)), Robert A. Rollins(Pfizer (United States))
Cited by 45
Related Papers
No related papers found
Powered by citation graph analysis